Gene · 2213
NIH grants2,625
NIH grants whose papers are about the gene, through NIH's grant-paper links.
861 to 880 of 2,625
Download this page as JSON| Grant | Title | FCGR2B papers | Newest fiscal year |
|---|---|---|---|
| P01AI131365 | Viral dynamics of rebound and control following early treatment of HIV/SIV | 2 | 2021 |
| R01AI129795 | Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir | 2 | 2021 |
| R01AI129797 | Optimization of Broadly Neutralizing Antibodies for HIV Eradication | 2 | 2021 |
| R01AI130010 | Diversity of TFH cells and DSA generation after kidney transplantation | 2 | 2021 |
| R01AI132317 | Germline targeting influenza immunogens | 2 | 2021 |
| R01AI142872 | Induction of food allergen-specific neonatal tolerance through breast milk | 2 | 2021 |
| R21AI149019 | Identification of novel Inhibitory receptors Involved In B cell tolerance | 2 | 2021 |
| RC2DK114777 | Niche signals in HSC genesis | 2 | 2021 |
| T32GM007365 | Medical Scientist Training Program | 2 | 2021 |
| T32GM007759 | Graduate Training in Molecular Biology and Biophysics | 2 | 2021 |
| U01AI131566 | Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface | 2 | 2021 |
| U01AI136677 | Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection | 2 | 2021 |
| F30AI140497 | Protective role of dectin-1 signaling in an animal model of Multiple Sclerosis | 1 | 2021 |
| F30AI143160 | Defining Features of Bacterial Control in M. tuberculosis Granulomas Using Single-cell mRNA Sequencing | 1 | 2021 |
| F31HL154537 | Investigating the contribution of rare coding variants to cardiovascular diseases | 1 | 2021 |
| I01CX001452 | How Does Nicotine Impair Macrophage Killing of Mycobacterium Tuberculosis? | 1 | 2021 |
| K01AG056841 | Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism | 1 | 2021 |
| K01DK106341 | Abnormal STAT3 Signaling and Aberrant O-Glycosylation of IgA1 in IgA Nephropathy | 1 | 2021 |
| K01HL135342 | CHD Risk and Metabolomic Profiles of Discordant Lipids | 1 | 2021 |
| K08AI130357 | Antibody Mediated Mechanisms of Immune Modulation in Tuberculosis | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/grants?page=44